SCHEMBL7245167

SCHEMBL7245167

COc1cccc(CNCc2ccc(CN)cc2)c1

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.66
ALDH1A1 P00352 1/20 0.66
HTT P42858 1/20 0.66
SMN1; SMN2 Q16637 1/20 0.66
HDAC1 Q13547 2/20 0.63
MAOB P27338 2/20 0.62
CHRM2 P08172 1/20 0.62
MEN1 O00255 1/20 0.61
KMT2A Q03164 1/20 0.61
HDAC3 O15379 1/20 0.58
HDAC2 Q92769 1/20 0.58
HDAC8 Q9BY41 1/20 0.58
TAAR1 Q96RJ0 3/20 0.57
BCHE P06276 3/20 0.53
IDO1 P14902 2/20 0.53
AGXT P21549 2/20 0.53
SCN8A Q9UQD0 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9416628 0.90 KDM4E (0.79) KDM4EALDH1A1HTTSMN1; SMN2HDAC1
SCHEMBL1134127 0.89 CHRM2 (0.74) KDM4EALDH1A1HTTSMN1; SMN2HDAC1
SCHEMBL30245831 0.88 KDM4E (0.77) KDM4EALDH1A1HTTSMN1; SMN2HDAC1
SCHEMBL8880839 0.88 KDM4E (0.77) KDM4EALDH1A1HTTSMN1; SMN2HDAC1
Hydrochloric Acid SCHEMBL6122475 0.88 CHRM2 (0.72) KDM4EALDH1A1HTTSMN1; SMN2HDAC1
SCHEMBL29947713 0.84 TAAR1 (0.71) ALDH1A1MAOBCHRM2TAAR1IDO1
SCHEMBL42954 0.84 TAAR1 (0.71) ALDH1A1MAOBCHRM2TAAR1IDO1
SCHEMBL4584077 0.83 CHRM2 (0.77) KDM4EALDH1A1HTTSMN1; SMN2CHRM2
SCHEMBL24343795 0.83 ALDH1A1 (0.61) KDM4EALDH1A1HTTSMN1; SMN2HDAC1
SCHEMBL18635836 0.83 HDAC1 (0.68) KDM4EALDH1A1HTTSMN1; SMN2HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6512000-B1 Aminocarbonyl- substituted benzimidazole derivatives for the treatment of diseases in which inhibition of tryptase is of therapeutic such as for treating an inflammatory or allergic disease BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-01-28 US disclosed